Black Rock Inc. Aspira Women'S Health Inc. Transaction History

Black Rock Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.32 - $0.58 $232 - $420	-725 Reduced 0.07%	991,931 $367,000
Q4 2022 Feb 13, 2023	SELL	$0.3 - $0.41 $277 - $379	-925 Reduced 0.09%	992,656 $327,000
Q3 2022 Nov 14, 2022	SELL	$0.38 - $1.07 $545 - $1,535	-1,435 Reduced 0.14%	993,581 $371,000
Q2 2022 Aug 12, 2022	SELL	$0.4 - $1.09 $1.48 Million - $4.02 Million	-3,692,065 Reduced 78.77%	995,016 $585,000
Q1 2022 May 12, 2022	SELL	$0.88 - $1.81 $60,945 - $125,353	-69,256 Reduced 1.46%	4,687,081 $4.87 Million
Q4 2021 Feb 10, 2022	BUY	$1.63 - $3.43 $135,513 - $285,159	83,137 Added 1.78%	4,756,337 $8.42 Million
Q3 2021 Nov 09, 2021	BUY	$3.19 - $5.48 $84,072 - $144,425	26,355 Added 0.57%	4,673,200 $15.2 Million
Q2 2021 Aug 11, 2021	BUY	$4.78 - $6.84 $22.2 Million - $31.8 Million	4,646,845 New	4,646,845 $26.1 Million

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.